BRD4 and osteosarcoma: Among them, MLLT3 [19], ATM/ATR [13,20,21], DDX10 [22,23,24], CASP1 [6] and BRD4 [25,26] have been extensively studied and shown to be associated with pathogenesis or clinical outcomes in osteosarcoma.